Community-based Communication for Blood Donation in Ghana
C-CAD
2 other identifiers
interventional
882
1 country
1
Brief Summary
A randomized controlled trial to evaluate the effectiveness of the WhatsApp groups or docudrama compared to a control group (usual engagement with blood services) on repeat blood donation attempts among first-time blood donors in Ghana. Secondary outcomes will be blood donor retention, blood donation knowledge, attitudes, beliefs, motivations, intention to donate, and relatedness as potential mediators of blood donation behavior among first-time blood donors. The RCT will have three arms: 1. WhatsApp; 2. docudrama; 3. control. Each participant in the WhatsApp and docudrama arms will receive the intervention for 14 months. Participants in the control arm will receive standard national blood donation communications and be followed for 14 months. Actualized blood donation is possible every four months using NBSG guidelines; consequently, participants may make multiple blood donation attempts. Return blood donation attempts will be evaluated using the Southern Zonal Blood Center (SZBC) records (primary outcome) and participant self-report (secondary outcome) at 7 months and 14 months. Secondary measures will be evaluated at baseline, 7 and 14 months from enrollment. The duration of the RCT will be 26 months allowing for 12 months to achieve enrollment goals and 14 months of follow-up for the last individual enrolled.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2023
CompletedFirst Posted
Study publicly available on registry
August 3, 2023
CompletedStudy Start
First participant enrolled
January 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 26, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 26, 2026
CompletedApril 14, 2026
April 1, 2026
2.2 years
July 25, 2023
April 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion with a repeat donation attempt
The primary outcome for the RCT will be the number of blood donation attempts
14 months
Study Arms (3)
Participants assigned to the WhatsApp arm will receive messages, audios, images and videos in a moderated, closed WhatsApp group over a 14-month duration. The messages aim to motivate blood donation, encourage participants to discuss their blood donation experiences, and allow them to share their motivations for donating blood.
docudrama
EXPERIMENTALParticipants randomized to this arm will meet three times (Month 2; Month 5 and Month 10), in a group setting, during the intervention. Each group will have a maximum of 20-40 participants. This is a stand-alone activity, which is not associated with a donation event. During each meeting, participants will be asked to watch, in the group setting, an episode of drama, lasting 15 minutes. The docudrama on blood donation will address participant's concerns regarding blood donation and address common donor fears.
control
NO INTERVENTIONstandard of care for repeat blood donation
Interventions
Participants assigned to the WhatsApp arm will receive messages, audios, images and videos in a moderated, closed WhatsApp group over a 14-month duration. The messages aim to motivate blood donation, encourage participants to discuss their blood donation experiences, and allow them to share their motivations for donating blood.
Participants randomized to this arm will meet three times (Month 2; Month 5 and Month 10), in a group setting, during the intervention. Each group will have a maximum of 20-40 participants. This is a stand-alone activity, which is not associated with a donation event. During each meeting, participants will be asked to watch, in the group setting, an episode of drama, lasting 15 minutes. The docudrama on blood donation will address participant's concerns regarding blood donation and address common donor fears.
Eligibility Criteria
You may qualify if:
- At least 18 years-old
- First-time whole blood donor with the SZBC of the NBSG
- Eligible to donate again at the time of eligibility confirmation
- Consent to participate
- Understands one of English, Twi, or Ga
- Have a smart phone
- Have, or be willing to sign up for an active WhatsApp account
- Be willing to watch a docudrama on blood donation in a group setting
You may not qualify if:
- History of more than one lifetime whole blood donation (with any blood center)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Minnesotalead
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
- National Blood Service Ghanacollaborator
- University of Ghanacollaborator
- Syracuse Universitycollaborator
- Liverpool School of Tropical Medicinecollaborator
- University of Minnesota, Coordinating Centers for Biometric Researchcollaborator
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55414, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2023
First Posted
August 3, 2023
Study Start
January 15, 2024
Primary Completion
March 26, 2026
Study Completion
March 26, 2026
Last Updated
April 14, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
The BLOODSAFE project is committed to quickly sharing results and data. Papers will be submitted summarizing the primary results of the BLOODSAFE studies once the analysis is complete. These results will be published in major scientific journals and presented at scientific meetings.